Panitumumab - Wikipedia
Panitumumab, sold under the brand name Vectibix, is a fully human monoclonal antibody specific to the epidermal growth factor …
Panitumumab Uses, Side Effects & Warnings - Drugs.com
Jul 28, 2025 · Panitumumab is used to treat a certain type of metastatic colorectal cancer that has progressed after treatment with …
Wild-Type RAS mCRC Treatment | Vectibix® (panitumumab)
Learn about Vectibix (panitumumab), a treatment for people with metastatic colorectal cancer, and a wild-type RAS gene. See …
Panitumumab - NCI - National Cancer Institute
Oct 5, 2006 · This page contains brief information about panitumumab and a collection of links to more information about the use of …
Panitumumab (intravenous route) - Side effects & uses
Mar 1, 2026 · Panitumumab injection is used alone or in combination with other medicines to treat metastatic cancer (cancer that …
Vectibix (panitumumab) is a recombinant, human IgG2 kappa monoclonal antibody that binds specifically to the human epidermal …
Anti-EGFR Therapy for WT RAS mCRC | Vectibix® (panitumumab)
Retrospective subset analyses across several randomized clinical trials were conducted to investigate the role of RAS mutations on …
Vectibix: Uses, Dosage, Side Effects, & Warnings - Drugs.com
Jan 21, 2025 · Before you receive this medicine, you may need to undergo a biopsy to make sure panitumumab is the right …
Panitumumab (Vectibix®) - OncoLink
Jan 28, 2025 · Panitumumab is an EGFR inhibiting monoclonal antibody used in the treatment of metastatic colorectal cancer with …
Panitumumab - Chemocare
What is this medication? PANITUMUMAB (pan i TOOM ue mab) treats colorectal cancer. It works by blocking a protein that causes …